BSE Live
Jan 09, 16:01Prev. Close
4025.10
Open Price
4028.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 09, 15:57Prev. Close
4026.40
Open Price
4016.00
Bid Price (Qty.)
3963.40 (237)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 1,441.18 | 1,188.71 | 1,001.90 | 895.16 | 744.33 | |
| Less: Excise/Sevice Tax/Other Levies | 4.16 | 4.26 | 5.64 | 8.82 | 48.93 | |
| Revenue From Operations [Net] | 1,437.02 | 1,184.46 | 996.25 | 886.34 | 695.41 | |
| Total Operating Revenues | 1,437.02 | 1,184.46 | 996.25 | 886.34 | 695.41 | |
| Other Income | 30.69 | 9.28 | -6.58 | 4.89 | 3.32 | |
| Total Revenue | 1,467.71 | 1,193.74 | 989.68 | 891.23 | 698.73 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 447.65 | 413.63 | 315.25 | 297.89 | 258.88 | |
| Purchase Of Stock-In Trade | 61.68 | 54.29 | 50.84 | 76.20 | 32.11 | |
| Operating And Direct Expenses | 27.65 | 24.30 | 17.59 | 17.77 | 17.05 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 1.48 | -11.50 | 20.45 | -30.78 | -4.30 | |
| Employee Benefit Expenses | 164.13 | 133.18 | 114.94 | 110.81 | 77.44 | |
| Finance Costs | 28.88 | 38.25 | 20.87 | 20.34 | 8.80 | |
| Depreciation And Amortisation Expenses | 54.42 | 37.39 | 32.74 | 30.24 | 23.66 | |
| Other Expenses | 330.99 | 304.27 | 251.16 | 244.65 | 194.12 | |
| Total Expenses | 1,116.90 | 993.81 | 823.84 | 767.13 | 607.75 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 350.81 | 199.92 | 165.83 | 124.10 | 90.98 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 350.81 | 199.92 | 165.83 | 124.10 | 90.98 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 113.29 | 2.16 | 1.62 | 0.10 | 3.84 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -6.26 | -1.14 | 6.16 | 8.72 | 10.67 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 107.03 | 4.44 | 10.32 | 11.14 | 17.09 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 243.79 | 195.49 | 155.52 | 112.96 | 73.89 | |
| Profit/Loss From Continuing Operations | 207.37 | 186.73 | 155.52 | 112.96 | 65.83 | |
| Profit/Loss For The Period | 207.37 | 186.73 | 155.52 | 112.96 | 65.83 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 24.51 | 22.07 | 18.38 | 13.35 | 7.78 | |
| Diluted EPS (Rs.) | 24.51 | 22.07 | 18.38 | 13.35 | 7.78 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 161.52 | 145.37 | 125.05 | 96.17 | 108.70 | |
| Indigenous Raw Materials | 188.55 | 183.87 | 122.16 | 136.96 | 98.52 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.66 | 0.56 | 0.31 | 0.48 | 0.46 | |
| Indigenous Stores And Spares | 14.23 | 11.14 | 10.18 | 10.64 | 6.63 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 50.77 | 33.84 | 29.61 | 25.38 | 21.15 | |
| Tax On Dividend | 8.43 | 5.75 | 5.03 | 3.56 | 2.97 | |
| Equity Dividend Rate (%) | 120.00 | 80.00 | 70.00 | 60.00 | 50.00 |
09.01.2026
05.12.2025
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012